Showing 41-50 of 78 results for "".
- Psoriasis, Other Autoimmune Diseases Up Risk for CVDhttps://practicaldermatology.com/news/psoriasis-other-autoimmune-diseases-up-risk-for-cvd/2461323/Earlier research has suggested associations between some autoimmune disorders and a higher risk of cardiovascular disease, and now, a new study shows that nineteen of the most common autoimmune disorders seem to increase risk for developing heart disease. Patients with autoimmune disease have a s…
- La Roche-Posay Becomes the First-Ever Official Sunscreen of the US Openhttps://practicaldermatology.com/news/la-roche-posay-becomes-the-first-ever-official-sunscreen-of-the-us-open/2461314/La Roche-Posay is the official sunscreen partner of the US Open. Beginning with this year's US Open, La Roche-Posay will have a sun safety education booth in the South Plaza of the USTA Billie Jean King National Tennis Center, with two additional product sampling kiosks on the grounds. La Roche-P…
- Happify Health, Almirall Go Live with Digital Solution to Support Psoriasis Patientshttps://practicaldermatology.com/news/happify-health-almirall-go-live-with-digital-solution-to-support-psoriasis-patients/2461234/Happify Health and Almirall S.A.’s new digital platform Claro is live and now available to people with psoriasis in Spain, Italy and the United Kingdom. Claro was built to improve the mental well-being of people with psoriasis through cognitive behavioral therapy, positive psychology, and mindfulne…
- First Austrian Skin Cancer Patients Treated with Rhenium-SCT in New Studyhttps://practicaldermatology.com/news/first-austrian-skin-cancer-patients-treated-with-rhenium-sct-in-new-study/2461110/The first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT– for the treatment of non-melanoma skin cancer), according to OncoBeta GmbH. "This is an important step for better understanding efficacy and patient outcomes…
- Study Identifies 29 New Acne Risk Geneshttps://practicaldermatology.com/news/study-identifies-29-new-acne-risk-genes/2461082/Researchers have identified 29 regions of the genome that influence acne. The new findings may open up new avenues of treatment and help clinicians identify individuals at high risk of severe acne. The research is published in Nature Communications. To arrive at their findings, researchers analyz…
- Dermatologists Seeing High Rates of Hair Loss after COVID-19https://practicaldermatology.com/news/dermatologists-seeing-high-rates-of-hair-loss-after-covid-19/2461034/When Paula Diaz contracted COVID, she expected to lose her sense of smell and taste but not her hair. “I spent six days in the hospital being treated for the virus and several weeks after I came home, my hair started falling out in clumps,” says Paula, who added that she’s always had a beautiful,…
- New Global Initiative Aims to Improve Eczema Carehttps://practicaldermatology.com/news/new-global-initiative-aims-to-improve-eczema-care/2460913/The new Global Patient Initiative to Improve Eczema Care (GPIIEC) is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients with eczema and their caregivers. The global initiative, representing 11 patient organizations and su…
- OncoBeta Launches Study of Rhenium-SCT for Skin Cancerhttps://practicaldermatology.com/news/oncobeta-launches-study-of-rhenium-sct-for-skin-cancer/2460909/OncoBeta GmbH is starting a phase IV international multi-centre study evaluating the complete response rate of patients with non-melanoma skin cancer after treatment with Rhenium-SCT. The Rhenium-SCT utilizes the radioisotope Rhenium-188 in an epidermal application with optimal properties for the …
- Amgen, International Federation of Psoriasis Associations Launch UPLIFT Innovation Challengehttps://practicaldermatology.com/news/amgen-international-federation-of-psoriasis-associations-launch-uplift-innovation-challenge/2460862/Amgen and the International Federation of Psoriasis Associations are launching the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Innovation Challenge, a new global initiative that aims to foster the development of solutions to address a challenge that people living with…
- Two New Studies Suggest Age Is A Primary Determinant Of Melanoma Treatment Resistancehttps://practicaldermatology.com/news/two-new-studies-suggest-age-is-a-primary-determinant-of-melanoma-treatment-resistance/2460595/Age is a primary factor in treatment response in animal and laboratory models of melanoma cells, according to two new studies. The new findings by Johns Hopkins Kimmel Cancer Center and Johns Hopkins Bloomberg School of Public Health researchers, published Sept. 4 in Cancer Discovery and Oct. 23 …